Heparin Lithium; 9045-22-1; Heparin Lithium Salt

Name: Heparin Lithium; 9045-22-1; Heparin Lithium Salt
Brand: Nanjing Yanqiao Technology Co., Ltd.
SKU: 2042241202

Jiangsu, ChinaNanjing Yanqiao Technology Co., Ltd.

US$50.00

1-4 g

US$40.00

5+ g

Sample price:US$150.00/piece.Request sample

Product profile

Customization

Available

CAS No.

9045-22-1

Formula

Model NO.

YQPR0003

EINECS

686-293-1

Classification

Biochemical Reagents

Grade

Specific Usage

For Biological Purpose, Technical Grade, Pratical Use

Content

150iu/Mg

Usage

Laboratory Reagents, Teaching Reagents

Source

Habit Appellation

Heparin Lithium

Application

Industry, Agriculture

Property

Biochemical Reagent

Appearance

White Powder

Store

2-8

Potency

150iu/Mg

Purpose

Experimental Study

Transport Package

Plastic Bottle

Specification

500mg; 1g; 5g

Trademark

Origin

China

Production Capacity

90000pieces/Year

Key features

Versatile Application: Suitable for clinical biochemical, emergency examinations, and hemorheological projects.

Ion Stability: Does not interfere with the determination of other ions during blood testing.

Rapid Anticoagulation: Ensures sufficient blood anticoagulation when mixed 5-8 times immediately after collection.

Compatible with Separation Gel: Can be used with separation gel to obtain high-quality plasma samples.

Sterilization Option: Supports gamma ray irradiation sterilization with a dose of 8-25kGy.

Stable Storage: White amorphous powder stable at room temperature and easily soluble in water.

Flexible Packaging: Available in 500mg, 1g, and 5g options for various laboratory needs.

Company profile

Nanjing Yanqiao Technology Co., Ltd.

Jiangsu, China

Business Type: Trading CompanyExport Year: 2023-01-06Nearest Port: shanghaiAverage Response Time: ≤2.40hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryThe supplier operates across various industries, including chemical and pharmaceutical plants, but lacks robust R&D and quality management processes. Their financial data is current, but no insights into specific financial health are provided. They offer customization services but lack ODM and OEM capabilities. Their after-sales service and customer complaint handling procedures need improvement.

Supplier typeThe supplier is engaged in sales of diverse materials and products, including chemicals, medical devices, and cosmetics, indicating a wide business scope across various sectors.

After-Sales capabilityThe supplier's after-sales service is limited to providing technical support without written procedures for corrective and preventive actions.

R&D capabilityThe supplier has minimal R&D resources, no new products developed in the past year, and lacks ODM services or SDK availability.

Customization capabilityThe supplier offers flexible customization services, including minor and sample-based customizations, despite lacking ODM/OEM capabilities.